Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

antibodies

Camel-Derived Therapy Infiltrates Cells to Treat Multiple Sclerosis

IRP Mouse Study Shows Promise of Treatment Strategy

Tuesday, October 1, 2024

camel in the desert

Earth’s jungles, deserts, and oceans are chock-full of wonderous creatures that have inspired a wide array of cutting-edge technologies, from strong yet flexible clothes made of synthetic spider silk to the plant-derived aspirin and morphine that have long been used as painkillers. Over the past few years, scientists at NIH and elsewhere have added sharks and camels to that list due to unique molecules their immune systems make. IRP researchers recently showed that one of those molecules could potentially be used to treat the devastating neurological disease known as multiple sclerosis.

Taming Inflammation in the Intestines

IRP’s Warren Strober Breaks Down the Causes of Inflammatory Bowel Disease

Monday, December 4, 2023

man with stomach pains

For many, the holiday season brings expectations of delicious meals and treats with family and friends, but the nearly 1.6 million Americans who have inflammatory bowel disease (IBD) may need to skip these delights or endure serious digestive distress. It’s fitting, then, that the first week of December is Crohn’s and Colitis Awareness Week, an occasion that calls attention to the two conditions lumped together under the umbrella of IBD.

Of course, no awareness week is needed to remind IRP senior investigator Warren Strober, M.D., of the importance of learning more about those two conditions. An expert in how the immune system operates within the digestive system, Dr. Strober has spent decades looking for ways to provide relief for IBD sufferers.

Antibody Assault Shows Promise Against Dormant HIV

Treatment Strategy Could Mop Up Virus Hiding in Patients’ Bodies

Tuesday, November 14, 2023

antibodies attacking a virus

As temperatures drop in the fall, a variety of species from groundhogs to bears prepare to wait out the winter in their dens. Much like these animals, HIV also goes into hibernation when conditions are tough, a trait that has long stymied efforts to develop a cure. However, IRP researchers recently tested a promising strategy that might one day be used to flush out and kill dormant remnants of HIV.

The Boon of Blood

A Look Inside NIH’s Department of Transfusion Medicine

Wednesday, June 21, 2023

a patient receiving blood during a surgery

The essential role of blood in our bodies has been recognized as far back as the time of ancient Greece, when the Greek physician Hippocrates included it in his list of four ‘humors’ that influence our health and emotions. Since then, scientists have vastly expanded our understanding of the dark red liquid running through our veins and arteries. Nowadays, researchers and technicians like those in NIH’s Department of Transfusion Medicine (DTM) can not only safely remove blood from one person and transfuse it into another, but they can also transform it into incredible forms of therapy.

Teaming Up to Tackle Engineering Challenges

Innovation Awards Accelerate Development of New Research Techniques

Monday, September 19, 2022

scientist working with a robotic arm

Scientists spend years, even decades, intensely studying a specific disease or biological system, an approach that yields unrivaled knowledge. However, many important scientific questions require a deep understanding of several subjects. As a result, the IRP has numerous programs dedicated to encouraging scientists with different areas of expertise to work together.

One such program is the NIH Director’s Challenge Innovation Awards, which funds innovative, high-impact projects that require the cooperation of researchers in more than one of NIH’s Institutes and Centers. This year, the program selected six promising proposals with one foot in the disciplines of biology and medicine and another in engineering or the physical sciences.

IRP Pushes Forward in Fight Against Pandemic Virus

Many NIH Labs Remain Focused on COVID Research

Monday, February 14, 2022

SARS-CoV-2 virus particles

Since the early days of the COVID-19 pandemic, IRP researchers have been hard at work learning about the virus and developing ways to prevent and treat infections. That research remains as important as ever, particularly as the new Omicron variant of the virus continues to spread rapidly.

Fortunately, NIH’s Intramural Targeted Anti-COVID-19 Program (ITAC) has been providing IRP scientists with millions of dollars to support their research on the pandemic virus, known as SARS-CoV-2. Last week, the “I Am Intramural” blog discussed ITAC-funded efforts to learn about the biology of the virus and how it affects the body. This week, we’ll look at IRP projects focused on ways to track, treat, and prevent infections.

IRP Scientists Continue Efforts to Quell Pandemic

COVID-19 Research at NIH Show No Signs of Slowing

Wednesday, February 9, 2022

SARS-CoV-2 virus particle

It’s been more than two years since the first outbreak of COVID-19 occurred in China. During that time, amazing scientific advances have dramatically altered prevention and treatment for the illness, including the development of remarkably safe and effective vaccines. However, even with widespread vaccination, scientists predict that the disease will continue to circulate in society indefinitely, with seasonal ebbs and flows like the flu.

As a result, even as COVID-19 vaccine shots rolled out by the hundreds of millions, numerous IRP researchers continued studying the disease and the virus responsible for it. Many of these projects have been funded by the NIH’s Intramural Targeted Anti-COVID-19 Program (ITAC), an initiative that provides IRP researchers with funding for research related to COVID-19. Over the past year and a half, ITAC has provided more than $12 million to support a wide variety of projects — more than can be covered in just one blog post. Read on to learn about just a handful of the many ways IRP researchers are contributing to the fight against COVID-19, and stay tuned next week for another blog describing even more ITAC-funded COVID research.

Looking Back at a Pandemic Year

Photos Document NIH Response to COVID-19

Monday, March 15, 2021

walk-up COVID-19 testing stations at the at the National Institute of Environmental Health Sciences campus in North Carolina

This past January marked the one-year anniversary of NIH’s role in addressing COVID-19. For many, it has been a year of hardships and grief, but the race to subdue this new virus has also tapped into the resolve and ingenuity of IRP staff who have already helped create diagnostic tests, vaccines, and therapeutics. Let's take a look back to see a few examples of how IRP scientists and staff have contributed to the fight against COVID-19, as well as how the pandemic has changed life at the NIH.

An Ebola Therapy Two Decades in the Making

IRP Researcher Nancy Sullivan Led Development of Cutting-Edge Treatment

Wednesday, February 10, 2021

a volunteer receives an infusion of an experimental Ebola therapy during a phase I clinical trial

Twenty-four years before the novel coronavirus began spreading in Wuhan, China, an outbreak of another deadly virus burned through the city of Kikwit in what is now the Democratic Republic of Congo. Between January and August of 1995, 316 people are thought to have contracted Ebola, and 252 of them died. More than a decade later, a team of NIH infectious disease scientists would track down one of the survivors and use a sample of the individual’s blood to produce one of the first effective treatments for Ebola.

Pandemic Brings All Hands on Deck

IRP Investigators Begin Hundreds of New Coronavirus-Related Studies

Monday, June 15, 2020

coronavirus particles (gold) emerging from an infected cell

Within just a few months after COVID-19 began spreading in the United States, IRP researchers had already made numerous important contributions to the fight against the deadly virus. Scientific knowledge about the disease continues to expand at a unprecedented pace, and the IRP will continue to play a major role in this effort over the coming months and years. In fact, nearly 300 new intramural research projects related to the novel coronavirus are currently starting up or have already begun.

  • Current page1
  • Page 22
  • Next pageNext ›
  • Last pageLast »

Blog menu

  • Contributing Authors
    • Anindita Ray
    • Brandon Levy
    • Devon Valera
    • Melissa Glim
  • Categories
    • IRP Discoveries
    • Profiles
    • Events
    • NIH History
    • IRP Life

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search